Related Experiment Video
Updated: Jul 17, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Gene therapy for viral hepatitis
Gloria Gonzalez-Aseguinolaza1, Julien Crettaz, Laura Ochoa
1University of Navarra, Division of Gene Therapy and Hepatology, Center for Applied Medical Research (CIMA), 31008 Pamplona, Spain. ggasegui@unav.es
Abstract:
Hepatitis B and C infections are two of the most prevalent viral diseases in the world. Existing therapies against chronic viral hepatitis are far from satisfactory due to low response rates, undesirable side effects and selection of resistant viral strains. Therefore, new therapeutic approaches are urgently needed. This review, after briefly summarising the in vitro and in vivo systems for the study of both diseases and the genetic vehicles commonly used for liver gene transfer, examines the existing status of gene therapy-based antiviral strategies that have been employed to prevent, eliminate or reduce viral infection. In particular, the authors focus on the results obtained in clinical trials and experimental clinically relevant animal models.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Gene Therapy
Gene Therapy
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors

